Gossamer Bio (GOSS)
(Delayed Data from NSDQ)
$2.99 USD
-0.09 (-2.92%)
Updated Sep 24, 2025 04:00 PM ET
After-Market: $2.99 0.00 (0.00%) 5:14 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Gossamer Bio, Inc. has a market cap of $700.33M, which represents its share price of $3.08 multiplied by its outstanding shares number of 227.38M. As a small-cap company, GOSS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GOSS 2.99 -0.09(-2.92%)
Will GOSS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GOSS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GOSS
Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
GOSS: What are Zacks experts saying now?
Zacks Private Portfolio Services
GSK (GSK) Q2 Earnings and Revenues Beat Estimates
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates
Other News for GOSS
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names
Technical picture remains unchanged for GOSS after it falls 2.53% on September 23
GOSS rises 3.61% on September 23, leaving the technical picture intact
MACD Bearish Signal Line Cross appears for GOSS after 0.97% move